Bizacumen Inc., Nov 2009, Pages: 436
Devices Likely to Get Good Reception in
EmergingMarkets 9
Awareness Drives European ProstateCancer Therapeutics Market 9
Global Industry Analysts, Inc., April 2009, Pages: 739
Good Reception in
EmergingMarkets II-5
Awareness Drives European ProstateCancer Therapeutics Market II-6
Growth Drivers
Life Science Intelligence, Inc., Jan 2011
isolation of an organ and local delivery of any high-dosage chemotherapy for treatment of organ cancer
- Occlusion device which provides men seeking a permanent form of contraception with a less-invasive
TriMark Publications, May 2011, Pages: 1784
and HPV Testing World Markets
- Molecular Diagnostics in Cancer Testing
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Until superior therapeutic treatments are developed to prevent
iData Research, March 2010, Pages: 440
analyses the markets for the treatment of:
- Benign Prostate Hyperplasia (BPH)
- Prostatecancer
- Urinary incontinence
- Urinary tract and kidney stones
The overall BPH treatmentdevices market includes
Jain PharmaBiotech, Feb 2012, Pages: 281
Transcutaneous electroporation for anticancer drugs
Transdermal drug delivery for prostatecancer
Transdermal nitroglycerine for prostatecancer
Transdermal estradiol gel for prostatecancer
Transdermal drug
Global Industry Analysts, Inc., July 2009, Pages: 227
Brachytherapy Revolutionizes ProstateCancerTreatment II-18
History Behind the Development II-18
Prostate Brachytherapy Procedure
Jain PharmaBiotech, Feb 2012, Pages: 780
of pancreatic cancer
Biomarkers of pancreatic cancer
Histone modifications predict treatment response in pancreatic cancer
Personlized management of prostatecancer
Diagnostics for guiding therapy of prostate
GBI Research, Dec 2011, Pages: 113
GBI Research's report, “Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment” provides key data
Jain PharmaBiotech, Feb 2012, Pages: 1029
for ovarian cancer
Pancreatic cancerProstatecancer
Early detection of prostatecancer recurrence by nanotechnology
Gene expression analysis of prostatecancer
Huntingtin Interacting Protein 1
Life Science Intelligence, Inc., Dec 2011, Pages: 605
device for convenient at-home sleep monitoring and analysis to: 1-offer insight into the diagnosis and treatment of conditions such as Alzheimer's, autism, cancer, epilepsy, depression, and schizophrenia
Jain PharmaBiotech, Feb 2012, Pages: 299
Atlas
Detection of cancer biomarkers
Sequencing mitochondrial DNA to identify cancer biomarkers
Biomarkers for personalizing cancertreatment
Digital proteomics for cancer profiling
Epigenome
GlobalData, Nov 2011, Pages: 40
, personalized treatment solutions which are used in the diagnosis of various cancers including prostatecancer, colorectal cancer, bladder cancer, breast cancer, lung cancer, cervical cancer. It also offers MGMT
TriMark Publications, Sep 2011, Pages: 343
Opportunities
2.1.1.3 Capital Markets
2.2 Cancer Detection and Treatment with Biomarkers
2.2.1 The Problem
2.3 Cancer: The Disease
2.3.1 Metastasis
2.3.2 Demographics and Statistics of Cancer
2.4 Drivers
GlobalData, May 2011, Pages: 124
.
The radiation therapy device market is forecast to grow at 10% to reach $3.5 billion by 2017. It will be driven by new sales in the emergingmarkets as well as replacement sales in developed countries
UBM Canon, Aug 2010, Pages: 70
vaccine advances in recent years is active immunotherapies, including the April 2010 FDA approval of Dendreon's Provenge, a personalized vaccine targeting prostatecancer. Active immunotherapy stimulates
GBI Research, March 2011, Pages: 194
and pipeline analysis for oncology, along with profiles of promising pipeline molecules in lung cancer, breast cancer, colorectal cancer, non-hodgkins lymphoma and prostatecancer.
- Detailed overview
